BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19328052)

  • 1. Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of Nostradamus.
    Trevisani F; Santi V
    Dig Liver Dis; 2009 Jun; 41(6):382-4. PubMed ID: 19328052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Why no consensus prognostic classification for hepatocellular carcinoma?].
    Barbare JC; Bellenguez A; Diouf M
    Rev Prat; 2013 Feb; 63(2):218-9. PubMed ID: 23513789
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinicopathological studies in patients with hepatocellular carcinoma. III. Clinical application of prognosis forecasting by computer (author's transl)].
    Nishioka M; Kan D; Nawata J; Takemoto T; Fukuda T; Miyaji T
    Rinsho Byori; 1980 Mar; 28(3):285-7. PubMed ID: 6246291
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting survival in early hepatocellular carcinoma.
    Ryder S
    Gut; 2005 Mar; 54(3):328-9. PubMed ID: 15710977
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure.
    Varela M; Forner A; Bruix J
    Liver Transpl; 2006 Oct; 12(10):1445-7. PubMed ID: 17004255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic imaging and therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum HE
    Dtsch Med Wochenschr; 1997 Dec; 122(50):1573-5. PubMed ID: 9445781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pedunculated (exophytic) hepatocellular carcinoma--a report of two cases].
    Wu G; Huang JZ; Gu HG
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):490. PubMed ID: 16042880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extrahepatic intrabile duct tumor growth of hepatocellular carcinoma].
    Kashihara T; Ohki A; Tako H; Kiso S
    Ryoikibetsu Shokogun Shirizu; 1996; (9):57-60. PubMed ID: 8705559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specific biomarkers for the diagnosis and prognosis of hepatocellular carcinoma].
    Wang HY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):241-3. PubMed ID: 21805729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrolamellar carcinoma of the liver. Apropos of 2 cases. Review of the literature].
    Azais-Noblinski B; Dahan D; Tubiana JM
    Ann Radiol (Paris); 1987; 30(6):395-9. PubMed ID: 2834992
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrolamellar carcinoma of the liver].
    Schechter D; Shefer R; Yosipov J; Inbar M; Messer G; Lelcuk S
    Harefuah; 1987 Oct; 113(7-8):160-1. PubMed ID: 2828202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases].
    Caselmann WH; Blum HE; Fleig WE; Huppert PE; Ramadori G; Schirmacher P; Sauerbruch T
    Z Gastroenterol; 1999 May; 37(5):353-65. PubMed ID: 10413843
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma. A clinical and pathological study of 33 cases.
    Tsakraklides V; Templeton AC; Estensen R; Good RA
    Minn Med; 1975 Jun; 58(6):450-3. PubMed ID: 167272
    [No Abstract]   [Full Text] [Related]  

  • 14. [Well-differentiated hepatocellular carcinoma].
    Umeshita K; Sakon M; Hasuike Y; Kanai T; Gotoh M; Monden M; Wakasa K; Sakurai M
    Ryoikibetsu Shokogun Shirizu; 1995; (7):470-2. PubMed ID: 8749528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathological studies in patients with hepatocellular carcinoma. V. Analysis of the numbers of parameters for prognosis forecasting (author's transl)].
    Nishioka M; Nawata J; Kan T; Kan M; Takemoto T; Fukuda T; Miyaji T
    Rinsho Byori; 1981 Mar; 29(3):309-11. PubMed ID: 6267338
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
    J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma.
    Shuto T; Yamamoto T; Tanaka S; Kanazawa A; Takemura S; Tanaka H; Kubo S; Hirohashi K; Sakaguchi H; Seki S
    J Gastroenterol; 2004 Sep; 39(9):907-8. PubMed ID: 15565415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and treatment of multicentric occurrence of hepatocellular carcinoma].
    He ZP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):187-9. PubMed ID: 15059316
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing hepatocellular carcinoma of early stage.
    Kondo F
    Acta Pathol Jpn; 1990 Nov; 40(11):860-1. PubMed ID: 1963996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.